Biotech Business - October 13, 2022
Mendus receives final grant payment
Mendus will receive 1.69 million EUR as the final grant payment from the Horizon 2020-funded AML-VACCiN project. All requirements for the final tranche have been fulfilled, bringing the total financial contribution from the European Commission to 6.0 million EUR for the project as a whole. As a result of the project completion, Mendus is now […]
Financing - October 4, 2022
Finnish startup brings to market a new type of NAD metabolite measurement technology
The medtech startup, NADMED, reveals the secrets of the human body at a metabolic level. The company’s technology is based on an invention created in Professor Anu Wartiovaara’s team at University of Helsinki. After years of rigorous studies, NADMED presents a solution which allows more profound and faster study of NADs, they describe in a […]
Biotech Business - September 12, 2022
Omnio receives capital injection of 1.5 million EUR
The capital investment from Omnio’s shareholders will be used for ongoing development work and to begin creating a blueprint for manufacturing. The company has already made a number of physician-led studies and successful trials involving patients with clinical wounds, they state in their press release. “It is unbelievable what some people have to go through […]
Biotech Business - September 8, 2022
Oncopeptides receives grant for multiple myeloma project
The company has received a research grant of 5 million SEK from Sweden’s Innovation Agency, to develop preclinical proof of concept for a novel synthetic small polypeptide for the treatment of multiple myeloma. “I am very proud and exhilarated that we have managed to attract world-leading expertise to our research consortium around NK-cell engagers,” said […]
Financing - September 1, 2022
ScandiDos has completed a directed share issue
ScandiDos has completed a directed share issue to IBA Dosimetry of 4,150,000 shares at a subscription price of 3 SEK per share, whereby the company receives approximately 12,45 million SEK before transaction costs. The strategic alliance that is being created between ScandiDos and IBA in quality assurance for radiation therapy enables a collaboration between the […]
Biotech Business - August 26, 2022
Mendus announces financing commitments totaling up to 250 MSEK
The company has entered into a binding agreement for a financing commitment with Negma Group (of up to 200 MSEK) as well as a binding commitment letter to receive a shareholder loan (up to 50 MSEK) with its existing shareholder Van Herk Investments. The financing commitments will allow the company to reach its next clinical […]
